Barclays Upgrades Agilent Technologies (NYSE:A) to Equal Weight
Agilent Technologies (NYSE:A – Get Free Report) was upgraded by equities researchers at Barclays from an “underweight” rating to an “equal weight” rating in a report issued on Monday, Marketbeat Ratings reports. The firm presently has a $145.00 price objective on the medical research company’s stock, up from their previous price objective of $135.00. Barclays‘s […]
Agilent Technologies (NYSE:A – Get Free Report) was upgraded by equities researchers at Barclays from an “underweight” rating to an “equal weight” rating in a report issued on Monday, Marketbeat Ratings reports. The firm presently has a $145.00 price objective on the medical research company’s stock, up from their previous price objective of $135.00. Barclays‘s […]
